Cigna Group/$CI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Ticker
$CI
Sector
Primary listing
NYSE
Employees
72,398
Headquarters
Website
Cigna Group Metrics
BasicAdvanced
$80B
16.41
$18.24
0.46
$5.93
2.02%
Price and volume
Market cap
$80B
Beta
0.46
52-week high
$350.00
52-week low
$256.89
Average daily volume
1.4M
Dividend rate
$5.93
Financial strength
Current ratio
0.788
Quick ratio
0.642
Long term debt to equity
65.496
Total debt to equity
76.102
Dividend payout ratio (TTM)
31.63%
Interest coverage (TTM)
6.80%
Profitability
EBITDA (TTM)
11,408
Gross margin (TTM)
9.86%
Net profit margin (TTM)
1.92%
Operating margin (TTM)
3.73%
Effective tax rate (TTM)
21.37%
Revenue per employee (TTM)
$3,620,000
Management effectiveness
Return on assets (TTM)
3.98%
Return on equity (TTM)
13.18%
Valuation
Price to earnings (TTM)
16.41
Price to revenue (TTM)
0.31
Price to book
1.98
Price to tangible book (TTM)
-2.43
Price to free cash flow (TTM)
20.689
Free cash flow yield (TTM)
4.83%
Free cash flow per share (TTM)
14.465
Dividend yield (TTM)
1.98%
Forward dividend yield
2.02%
Growth
Revenue change (TTM)
20.23%
Earnings per share change (TTM)
43.31%
3-year revenue growth (CAGR)
13.45%
10-year revenue growth (CAGR)
21.74%
3-year earnings per share growth (CAGR)
2.76%
10-year earnings per share growth (CAGR)
8.49%
3-year dividend per share growth (CAGR)
11.14%
10-year dividend per share growth (CAGR)
64.55%
What the Analysts think about Cigna Group
Analyst ratings (Buy, Hold, Sell) for Cigna Group stock.
Bulls say / Bears say
Cigna beat second-quarter 2025 earnings estimates, reporting $7.20 per share on Evernorth revenue of $57.83 billion—a 17% year-over-year increase—and maintained its full-year adjusted profit outlook (Reuters)
In Q1 2025, Cigna exceeded profit forecasts with adjusted operational income of $6.74 per share versus $6.35 expected, and raised its full-year EPS guidance to at least $29.60, reflecting strong PBM performance and lower medical costs (Reuters)
The strategic divestment of its Medicare business to Health Care Service Corp has insulated Cigna from government-backed plan cost pressures, allowing a focused investment in higher-margin pharmacy benefit management and commercial health insurance (Reuters)
Medical care ratio rose to 83.2% in Q2 2025, up from prior levels, signaling increased stop-loss medical costs that could pressure Cigna’s profit margins (Reuters)
Cigna’s stop-loss insurance plans incurred elevated costs in Q4 2024, leading to a miss in that period and underscoring volatility in a key risk-bearing segment (Reuters)
Arkansas has introduced legislation aiming to break up integrated PBMs such as Cigna’s Express Scripts, reflecting mounting state-level legal and regulatory threats to its pharmacy benefit management operations (FT)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
Cigna Group Financial Performance
Revenues and expenses
Cigna Group Earnings Performance
Company profitability
Cigna Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cigna Group stock?
Cigna Group (CI) has a market cap of $80B as of October 20, 2025.
What is the P/E ratio for Cigna Group stock?
The price to earnings (P/E) ratio for Cigna Group (CI) stock is 16.41 as of October 20, 2025.
Does Cigna Group stock pay dividends?
Yes, the Cigna Group (CI) stock pays dividends to shareholders. As of October 20, 2025, the dividend rate is $5.93 and the yield is 2.02%. Cigna Group has a payout ratio of 31.63% on a trailing twelve-month basis.
When is the next Cigna Group dividend payment date?
The next Cigna Group (CI) dividend payment date is unconfirmed.
What is the beta indicator for Cigna Group?
Cigna Group (CI) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.